Table 5 Table of expected adverse events
Event | Further details (where applicable) |
|---|---|
Acidosis | |
Arrhythmias | Including: -Supraventricular tachycardia or atrial fibrillation requiring treatment -VF/VT requiring intervention |
Aspiration of stomach contents | |
Bleeding | Requiring: -Transfusion -Return to theatre |
Escalation of respiratory support | For example: (unplanned NIV/CPAP/re-intubation and invasive ventilation) |
GI complications | Including: -Peptic ulcer/GI bleed/perforation -Pancreatic (amylase /1500iu) -Other (e.g. laparotomy, obstruction) |
Haemodynamic support | Including use of: -Any inotropes -Intra-aortic balloon pump (IABP) -Need for invasive monitoring, e.g. pulmonary artery catheter -Vasodilator |
Infective complications | Including: -Wound infection -Respiratory infection -Sepsis |
Low cardiac output state | Requiring management with: -Swan-Ganz catheter -IABP -Left ventricular assist device |
Mediastinitis | Including: -Requiring reoperation |
Neurological complications | Including: -Stroke -Transient ischaemic attack (TIA) |
Pain in sternal wound/legs/arms incision sites | |
Pneumothorax | |
Pulmonary complications | Including: -Re-intubation and ventilation -Tracheostomy -Initiation of mask CPAP ventilation after weaning from ventilation -ARDS |
Re-admission to ICU | |
Renal complications | Including: -New haemofiltration/dialysis -Acute kidney injury |
Resternotomy | |
Thromboembolic complications | Including: -Deep vein thrombosis -Pulmonary embolus |
Wound dehiscence requiring rewiring or treatment | |